HTGF's Capical receives series-A funding

The capital will be used to promote national and international sales of the company's first product c one, a capacitive electrocardiogram (ECG) device. c one received official approval as a medical product at the beginning of the year.

HTGF initially invested in Capical in 2011.

M-Invest typically invests in safe investment options like property, stocks, solar systems and start-ups in various industries such as medicine.

Company
Capical was founded in 2010 in Braunschweig, Germany. Capical seeks to establish the internally-developed capacitive ECG technology in everyday clinical life. Its first medical product, c one, is now approved for use and is designed to provide an accurate ECG reading within 30 seconds, with the aim to save crucial time in the diagnosis of heart attacks.

People
Martin Oehler, Henning Böge and Meinhard Schilling are the co-founders of Capical. Susanne Rübenach is an investment manager for ERP-Startfonds at KfW. Kay Balster is an investment manager at HTGF.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Early-stage
• Healthcare
• High-Tech Gründerfonds
• Germany